Article Figures & Data
Tables
Factor n (%) Age (years) 18-40 89 (65.0) 41-60 37 (27.0) >60 11 (8.0) Sex Female 71 (51.0) Male 66 (49.0) Marital status Single 37 (27.0) Married 93 (67.8) Other 7 (5.1) Diagnosis Depression 62 (45.0) Anxiety disorders 49 (36.0) Obsessive Compulsive Disorder 21 (15.3) Other 5 (3.7) - Table 2
Antidepressants usage, average doses and mean duration of use for the participants in this study.
Antidepressant n Average dose in mg(SD) Mean duration of use in years (SD) Paroxetine 52 22.3 (8.4) 5.1 (3.2) Fluoxetine 36 25.5 (9.0) 2.7 (8.1) Mirtazapine 32 20.4 (9.3) 3.3 (3.9) Venlafaxine 17 94.8 (49.8) 4.5 (0.7) - Table 3
Comparison of the percentages of decreased libido, increased libido and anorgasmia between the male and female participants in this study.
Symptoms Male Female P-value * n (%) Increased libido 39 (59.0) 27 (38.0) 0.001 Decreased libido 46 (69.6) 38 (53.5) 0.265 Anorgasmia 45 (68.1) 37 (52.1) 0.054 ↵* Pearson chi-square test was used to test the relationship between the 2 variables and the differences was considered statistically significant if the p-value <0.05
Fluoxetine (%) Mirtazapine(%) Paroxetine(%) Venlafaxine(%) p-value* Decreased libido (29.4) (28.0) (59.6) (47.0) 0.189 Increased libido (26.4) (21.8) (25.0) (29.4) 0.996 Premature ejaculation (33.3) (46.1) (62.0) (77.0) 0.466 Delayed ejaculation (22.2) (30.7) (34.4) (22.2) 0.909 Anorgasmia (35.2) (28.1) (48.0) (52.9) 0.240 Erectile dysfunction (27.7) (38.4) (44.8) (44.4) 0.635 ↵* Pearson chi-square test was used to test the relationship between the 2 variables and the differences was considered statistically significant if the p-value <0.05